ArticleCancer immunology, immunotherapy : CII2009

Treatment of non-Hodgkin's lymphoma xenografts with the HB22.7 anti-CD22 monoclonal antibody and phosphatase inhibitors improves efficacy.

Robert T O'Donnell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.